Hyperkalaemia has been observed in a few individuals during drosperinone 4mg use, although in most cases no increase in potassium level is to be expected. For individuals with risk factor for potassium elevation (renal impairment, hypoadrenalism, potassium-sparing medications) please consult the SmPC and CoSRH POP guidance for advice and recommended monitoring.